Case Report: Atypical hepatobiliary manifestations associated with erythrocyte membrane instability in glucose transporter type 1 deficiency syndrome - Scorecard - MDSpire

Case Report: Atypical hepatobiliary manifestations associated with erythrocyte membrane instability in glucose transporter type 1 deficiency syndrome

  • By

  • Hahnbie Lee

  • Sook Won Ryu

  • Jeana Hong

  • May 20, 2026

  • 0 min

Share

Clinical Scorecard: Clinical Case Study: Uncommon Hepatobiliary Complications Linked to Erythrocyte Membrane Instability in GLUT1 Deficiency Syndrome

At a Glance

CategoryDetail
ConditionGLUT1 Deficiency Syndrome (GLUT1DS)
Key MechanismsPathogenic variants in SLC2A1 leading to glucose transport deficiency and erythrocyte membrane instability.
Target PopulationPediatric patients diagnosed with GLUT1DS.
Care SettingMultidisciplinary care including pediatric gastroenterology and neurology.

Key Highlights

  • GLUT1DS primarily presents with neurological symptoms but can have atypical hematologic and hepatobiliary manifestations.
  • Case of a boy with GLUT1DS exhibiting recurrent jaundice, anemia, and abdominal pain due to chronic hemolysis.
  • Erythrocyte membrane instability linked to GLUT1 dysfunction was identified through specialized testing.
  • Need for hepatobiliary surveillance in GLUT1DS patients beyond neurological care.
  • Ketogenic diet is the standard therapy for neurological symptoms in GLUT1DS.

Guideline-Based Recommendations

Diagnosis

  • Genetic testing for SLC2A1 variants to confirm GLUT1DS diagnosis.

Management

  • Initiate a ketogenic diet for neurological symptom management.

Monitoring & Follow-up

  • Regular assessment of bilirubin levels and erythrocyte membrane integrity.

Risks

  • Potential for recurrent jaundice, anemia, and hepatobiliary complications.

Patient & Prescribing Data

Children diagnosed with GLUT1DS.

Management may require a multidisciplinary approach, including dietary interventions and monitoring for atypical complications.

Clinical Best Practices

  • Conduct thorough genetic testing for atypical presentations of GLUT1DS.
  • Implement multidisciplinary care strategies for comprehensive management.
  • Monitor for hematologic and hepatobiliary complications in GLUT1DS patients.

Related Resources & Content

Original Source(s)

Related Content